Amprenavir: Difference between revisions
Jump to navigation
Jump to search
imported>David E. Volk mNo edit summary |
imported>David E. Volk m (→External Links: drug templates) |
||
| Line 12: | Line 12: | ||
== External Links == | == External Links == | ||
* {{DailyMed}} | * {{DailyMed}} | ||
* | * {{MedMaster}} | ||
* {{DrugBank}} | |||
Revision as of 12:24, 5 March 2008
Amprenavir, also called AMP, AMV, APV and VX-478, is a protease inhibitor used to treat HIV infection. Protease inhibitors block HIV-1 protease, an enzyme required for the proteolytic cleavage of the viral polyprotein precursors into the individual functional proteins found in infectious HIV-1. Protease inhibitors are almost always used in combination with at least two other anti-HIV drugs. Its IUPAC chemical name is [(3S)-oxolan-3-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3- hydroxy-1-phenylbutan-2-yl]carbamate.
Brand Names
- Agenerase®
- Prozei®
- Vertex®
External Links
- Amprenavir - FDA approved drug information (drug label) from DailyMed (U.S. National Library of Medicine).
- Template:MedMaster
- Template:DrugBank